[Speaker]
Seo Young Lee
Seo-Young Lee1, So-ryoung Lee2, Soonil-Kwon2, Eue-Keun Choi2, Kyung-Do Han3, Myung-Jin Cha2, Seil Oh2
1Department of Hospital Medicine Center, Seoul National University Hospital, Seoul, Republic of Korea
2Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
3Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
Smoking cessation after diagnosis of new-onset atrial fibrillation and the risk of stroke and death
[Speaker]
So-Ryoung Lee
So-Ryoung Lee, MD,1 Eue-Keun Choi, MD, PhD,1 Jin-Hyung Jung, BSc,2 Kyung-Do Han, PhD,2,3 Seil Oh, MD, PhD,1 Gregory Y. H. Lip, MD1,4,5
1 Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
2 Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
3 Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
4 Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest & Heart Hospital, Liverpool, United Kingdom; and 5 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
New-onset Paroxysmal Atrial Fibrillation in Acute Myocardial Infarction: Increased Risk of Stroke
[Speaker]
Ji Hyun Lee
Ji Hyun Lee, Sun-Hwa Kim, Wonjae Lee, Youngjin Cho, Si-Hyuck Kang, Jin Joo Park, Il-Young Oh, Chang-Hwan Yoon, Jung-Won Suh, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi
Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea
[Speaker]
Boyoung Joung
Boyoung Joung, MD1, Pil-Sung Yang, MD2, Jung-Hoon Sung, MD 2, Tae-Hoon Kim, MD1, Eunsun Jang, MS1, Hee Tae Yu, MD1, Hui-Nam Pak, MD1, Moon-Hyoung Lee, MD1
1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
The usefulness of anticoagulation in atrial fibrillation patients with end stage renal disease
[Speaker]
Hyuk Kyoon Park
Hyuk Kyoon Park, MDa, Se Yong Jang, MDa,b, Myung Hwan Bae, MDa,b, Jang Hoon Lee, MDa,b, Dong Heon Yang, MDa,b, Hun Sik Park, MDa,b, Yongkeun Cho, MDa,b, and Shung Chull Chae, MDa,b on behalf of KorAHF investigators
aDepartment of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea; bSchool of Medicine, Kyungpook National University, Daegu, Republic of Korea
[Speaker]
Kiyoung Boo
Ki Yung Boo1, Jaemin Shim2, Yun Young Choi2, Ha Young Choi2, Do Young Kim2, Yun Gi Kim2, Kwang-No Lee2, Jong-Il Choi2, Young-Hoon Kim2
1 Division of Cardiology, Department of Internal Medicine, Jeju National University Hospital, Jeju, Republic of Korea
2 Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Medical Center, Seoul, Republic of Korea
[Speaker]
Minsoo Kim
Minsoo Kim, MD1*; Min
Soo Cho, MD1*; Gi-
Byoung Nam, MD1; Tae
Oh Kim, MD1;
Ungjeong Do, MD1; Jun
Kim, MD1; Kee-Joon
Choi, MD1; You-Ho
Kim, MD1
Asan Medical center,
University of Ulsan
College of Medicine,
Seoul, Korea1